DAIICHI SANKYO COMPANY,LIMITED

4568

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-07-31FY2027 Q1

Revenue

2.22T JPY

YoY +15.5%

Operating Income

851100M JPY

YoY -12.0%

Net Income

2628.7100M JPY

YoY -11.2%

EPS

37.7JPY

YoY -18.1%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

2.1兆円

1.6兆円

1.1兆円

5307.6億円

Rev: 1兆円Op: 730.3億円NI: 669.7億円

Rev: 1.3兆円Op: 1205.8億円NI: 1091.9億円

Rev: 1.6兆円Op: 2115.9億円NI: 2007.3億円

Rev: 1.9兆円Op: 3319.3億円NI: 2957.6億円

Rev: 2.1兆円Op: 2580.5億円NI: 2797.3億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income27.3%

Revenue Progress5747.400M

Revenue Forecast2.3T

Net Income Progress686.400M

Net Income Forecast251000M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan